Nervous system adverse responses to topiramate in the treatment of neuropsychiatric disorders.
about
Treatment of alcohol dependence with low-dose topiramate: an open-label controlled study.Clinical pharmacology of topiramate in migraine prevention.BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.Treatment of clozapine-associated weight gain: a systematic review.
P2860
Nervous system adverse responses to topiramate in the treatment of neuropsychiatric disorders.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nervous system adverse respons ...... of neuropsychiatric disorders.
@en
Nervous system adverse respons ...... of neuropsychiatric disorders.
@nl
type
label
Nervous system adverse respons ...... of neuropsychiatric disorders.
@en
Nervous system adverse respons ...... of neuropsychiatric disorders.
@nl
prefLabel
Nervous system adverse respons ...... of neuropsychiatric disorders.
@en
Nervous system adverse respons ...... of neuropsychiatric disorders.
@nl
P2860
P1476
Nervous system adverse respons ...... of neuropsychiatric disorders.
@en
P2093
Johannes A Carpay
P2860
P304
P356
10.1517/14740331003739196
P407
P577
2010-07-01T00:00:00Z